PDF
Full
Outline
OBJECTIVE To summarize the research progress and beneficiary population of immune re challenge in the treatment of non-small cell lung cancer (NSCLC), and provide reference for the treatment of NSCLC in clinical practice. METHODS Using keywords such as “non- small cell lung cancer”, “immune checkpoint inhibitor”, “rechallenge”, etc., a combination of topic words and free words was used to search relevant literature from PubMed、Cochrane Library、embase、self-built databases such as China National Knowledge Infrastructure until February 1, 2024. RESULTS A total of 526 relevant literature were retrieved, with over 40 valid articles. Among them, there are 6 systematic reviews/Meta analyses on NSCLC rechallenge, 5 clinical studies, and most of the rest are retrospective real-world studies. CONCLUSION The effectiveness and controllable irAEs of immune rechallenge therapy for NSCLC were analyzed, and it was preliminarily believed that patients with high programmed cell death ligand 1 (PD-L1) expression (TPS ≥ 50%), good performance status (PS) score in the Eastern Cooperative Oncology Group (ECOG) in the United States (ECOG-PS≤1) and longer initial immunotherapy time were more likely to benefit from ICIs rechallenge.
PDF
247
117
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62199257
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
